首页> 外文OA文献 >The evaluation of indomethacin and theophylline oral controlled/modified-release dosage forms : in vitro-in vivo correlations
【2h】

The evaluation of indomethacin and theophylline oral controlled/modified-release dosage forms : in vitro-in vivo correlations

机译:消炎痛和茶碱口服控释/调释剂型的评价:体内外相关性

摘要

Over the past few decades many researchers have investigated the utility of in vitro - in vivo correlations for the assessment of dosage forms. These investigations are, however, dependent on reproducible dissolution data and well conducted biostudies in order to establish meaningful and robust correlations. Despite the fact that the establishment of such correlations is perhaps idealistic, considerable interest has still been shown in this area of research.Various Controlled/Modified Release Dosage Forms (CMRD's) of theophylline, a weakly basic drug, and indomethacin, a weakly acidic drug, were assessed in order to establish in vitro - in vivo correlations. Dissolution rate studies were carried out using either the USP basket or paddle apparatus. The dissolution rate studies were conducted in a range of dissolution media of varying pH. Bioavailability studies were conducted on the dosage forms used by the Biopharmaceutics Research Institute at Rhodes University. The results of these biostudies were kindly made available for use in this research project.Type A correlations were established using a mathematical simulation process whereby expected in vivo responses are simulated and compared to actual profiles obtained for the dosage forms. In order to perform the simulations the dissolution rate profiles were stripped and using linear regression and the methods of residuals the dissolution rate order and the relevant dissolution rates were obtained. The results of the s imulations indicated that the in vivo serum concentration-time curves could be accurately predicted for the theophylline dosage forms but to a lesser extent, for the indomethacin formulations.The dissolution rate studies indicated that the paddle method is a suitable method for dissolution rate studies of theophylline CMRD's, although it appeared that the optimum pH of the dissolution medium was formulation dependent. Dissolution rate studies conducted on indomethacin formulations indicated that the USP specified basket method for extended-release indomethacin formulations was not able to distinguish between two formulations which exhibited different in vivo profiles. The conversion to the paddle method was, however, able to highlight the differences between these formulations.The use of three dimensional topographs to depict dissolution rate profiles was demonstrated for formulations of both theophylline and indomethacin. The topographs enabled the successful differentiation between bioinequivalent formulations. The dissolution rate profiles were also fitted to the Wei bull equation and the parameters obtained from this were compared to the Weibull parameters obtained from the in vivo absorption plots obtained using the Wagner-Nelson method. The results indicated that the Weibull function was suitable to describe both the in vivo and in vitro data.The following recommendations for the preformulation dissolution studies of weakly acidic and weakly basic drugs are proposed. The dissolution rate studies of weakly acid drugs, such as indomethacin, should be carried out over a range of pH utilising the paddle apparatus. Three dimensional topographs based on the dissolution data should be constructed and used as a comparative tool for different formulations. Based on these comparisons the appropriate formulation can then be selected for a pilot scale in vivo bioavailability study.The dissolution rate studies of weakly basic drugs, such as theophylline, should be carried out over a range of pH utilising the paddle apparatus. The dissolution data should then be used to simulate the expected in vivo profile and on this basis the appropriate formulation selected for a pilot scale bioavailability study. The above approach to the preformulation studies of new CMRO's would allow for the more careful selection of new dosage forms and could thus eliminate costly and unnecessary bioavailability studies performed on inferior formulations.
机译:在过去的几十年中,许多研究人员研究了体外-体内相关性用于评估剂型的效用。但是,这些研究依赖于可再现的溶出度数据和进行良好的生物研究,以便建立有意义且稳定的相关性。尽管事实上建立这种相关性可能是理想的,但在该研究领域中仍显示出相当大的兴趣。弱碱药物茶碱和弱酸性药物吲哚美辛的各种控释/调释剂型(CMRD)为了建立体外-体内相关性,进行了评估。使用USP篮式或桨式装置进行溶出度研究。溶出度研究是在各种pH值不同的溶出介质中进行的。生物利用度研究是由罗德大学生物制药研究所使用的剂型进行的。这些生物研究的结果可用于本研究项目。使用数学模拟过程建立A型相关性,从而模拟预期的体内反应并将其与剂型获得的实际概况进行比较。为了进行模拟,剥离溶出速率曲线,并使用线性回归和残差方法,获得溶出速率顺序和相关溶出速率。模拟结果表明,茶碱剂型可准确预测体内血清浓度-时间曲线,但吲哚美辛制剂的体内血清浓度-时间曲线可预测较小。溶出度研究表明,桨法是一种合适的方法。茶碱CMRD的溶出度研究,尽管看来溶出介质的最佳pH取决于制剂。对消炎痛制剂的溶出度研究表明,USP规定的用于缓释消炎痛制剂的篮子方法无法区分显示出不同体内特征的两种制剂。然而,向桨法的转换能够突出这些制剂之间的差异。已证明对于茶碱和消炎痛制剂,使用三维地形图描绘溶出速率曲线。地形图使生物等效制剂之间的成功区分成为可能。溶出速率曲线也适用于Wei Bull方程,并将由此获得的参数与从使用Wagner-Nelson方法获得的体内吸收图获得的Weibull参数进行比较。结果表明,Weibull函数适合描述体内和体外数据。对弱酸性和弱碱性药物的制剂前溶出度研究提出以下建议。弱酸性药物(如吲哚美辛)的溶出度研究应在pH值范围内使用桨式仪器进行。应基于溶出度数据构建三维地形图,并将其用作不同配方的比较工具。基于这些比较,可以选择合适的制剂用于中试规模的体内生物利用度研究。弱碱性药物(如茶碱)的溶出度研究应在pH范围内使用桨式仪器进行。然后应将溶出度数据用于模拟预期的体内分布,并在此基础上选择用于中试规模生物利用度研究的合适制剂。以上用于新CMRO的预制剂研究的方法将允许更仔细地选择新剂型,从而可以消除对劣等制剂进行的昂贵且不必要的生物利用度研究。

著录项

  • 作者单位
  • 年度 1992
  • 总页数
  • 原文格式 PDF
  • 正文语种 {"code":"en","name":"English","id":9}
  • 中图分类
  • 入库时间 2022-08-20 20:17:16

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号